NEW YORK (
) hit a new 52-week high Wednesday as it is currently trading at $17.35, above its previous 52-week high of $17.21 with 130,013 shares traded as of 11:56 a.m. ET. Average volume has been 180,200 shares over the past 30 days.
Quidel has a market cap of $550.7 million and is part of the
industry. Shares are up 9.5% year to date as of the close of trading on Tuesday.
Quidel Corporation develops, manufactures, and markets diagnostic testing solutions for applications in infectious diseases, women's health, and gastrointestinal diseases. The company has a P/E ratio of 553.3, below the average drugs industry P/E ratio of 830 and above the S&P 500 P/E ratio of 17.7.
- Practice your QDEL trading strategies and win cash in our stock game.
TheStreet Ratings rates Quidel as a
. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures and good cash flow from operations. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, disappointing return on equity and feeble growth in the company's earnings per share. You can view the full
52-week high stocks
or get investment ideas from our